OKYO Pharma Ltd (NASDAQ:OKYO), focused on developing treatments for neuropathic corneal pain and dry eye disease, announced CEO Dr. Gary Jacob will join the 4th Annual Virtual BTIG Ophthalmology Day on December 2, 2024.
Dr. Jacob will participate in one-on-one meetings and a fireside chat from 2:40-3:15 PM.
The event features over 20 companies discussing advancements in ophthalmic technologies and therapeutics, highlighting innovations in the multi-billion-dollar eye care market.